HLA-DRA anticorps
-
- Antigène Voir toutes HLA-DRA Anticorps
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Reactivité
- Humain, Singe
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp HLA-DRA est non-conjugé
-
Application
- Flow Cytometry (FACS), Immunofluorescence (IF)
- Specificité
- MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50 % of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70 % of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected. '
- Purification
- Purified by Protein A/G
- Immunogène
- Spleen cells of a patient with hairy cell leukemia (Daudi cells)
- Clone
- IPO-10
- Isotype
- IgG3 kappa
- Top Product
- Discover our top product HLA-DRA Anticorps primaire
-
-
- Indications d'application
-
Positive Control: Ramos, Daudi or HuT78 cells. Tonsil or lymph node.
Known Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Optimal dilution for a specific application should be determined.
- Restrictions
- For Research Use only
-
- Concentration
- 200 μg/mL
- Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-80 °C
- Stockage commentaire
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
- Date de péremption
- 24 months
-
- Antigène
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
- Autre désignation
- HLA-DRA (HLA-DRA Produits)
- Synonymes
- anticorps HLA-DRA1, anticorps MLRW, anticorps DR-alpha, anticorps HLA-DRA, anticorps Mamu-DRA1, anticorps major histocompatibility complex, class II, DR alpha L homeolog, anticorps major histocompatibility complex, class II, DR alpha, anticorps hla-dra.L, anticorps HLA-DRA, anticorps MAMU-DRA, anticorps BOLA-DRA
- Poids moléculaire
- ~36kDa
- ID gène
- 3122
- UniProt
- P01903
- Pathways
- TCR Signaling, CXCR4-mediated Signaling Events
-